期刊文献+

食管鳞癌组织中CD44v6与E-钙黏蛋白表达及其临床意义 被引量:1

The expression and clinical significance of CD44v6 and E-cadherin in the esophageal squamous cell carcinoma
原文传递
导出
摘要 目的探讨食管鳞癌组织CD44v6与E-钙黏蛋白(E-cad)表达与其临床病理特征的关系。方法采用免疫组化法检测48例食管鳞癌(A组)、23例糜烂性食管炎(B组)和24例正常食管黏膜组织(C组)CD44v6和E-cad的表达,分析其表达与食管鳞癌临床病理特征的关系。结果 A组CD44v6表达明显高于B、C组,而E-cad表达明显低于B、C组(P<0.05)。CD44v6和E-cad的表达与食管鳞癌浸润深度和淋巴结转移密切相关(P<0.05)。食管鳞癌组织中CD44v6和E-cad表达水平呈负相关(r=-0.580,P<0.05)。结论联合检测病变组织中CD44v6与E-cad的表达有望成为食管鳞癌筛查及预后判断的辅助指标。 Objective To investigate the expression and clinical significance of CD44v6 and E-cadherin in the esophageal squamous cell carcinoma. Methods With immunohistochemistry, the expressions of CD44v6 and E-cadherin were detected in 48 esophageal squamous carcinoma tissues (group A),23 erosive esophagitis tissues(group B) and 24 normal esophagus tissues(group C). The relationship of the expressions of CD44v6 and E-cadherin and clinieopathological characteristics of esophageal squamous cell carcinoma were analyzed. Results Compared to groups of B and C, the expression of CD44v6 was higher, but that of E-cadherin was lower, in group A (P〈0. 05). The expressions of CD44v6 and E-cadherin were closely related to the depth of invasion and the status of lymph node metastasis of esophageal squamous cell carcinoma (P〈0. 05). The expression level of CD44v6 was negatively correlated with that of E-cadherin in group A (r=-0. 580, P〈0. 05). Conclusion Combined detection of CD44v6 and E-cadherin in diseased tissues is hopeful as the adjutant indicators in screening and predicting the prognosis of esophageal squamous cell carcinoma.
出处 《江苏医药》 CAS 北大核心 2013年第5期511-513,F0002,共4页 Jiangsu Medical Journal
基金 南京市医学科技发展基金资助项目(YKK08095)
关键词 食管鳞癌 CD44V6 E-钙黏蛋白 Esophageal squamous cell carcinoma CD44v6 E-cadherin
  • 相关文献

参考文献2

二级参考文献24

  • 1Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, TsengHH, Chou NH, Huang MS, Tseng CJ, Hsiao M. Loss of Ecadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas.Cancer Lett 2003; 201:97-106.
  • 2Karayiannakis AJ, Syrigos KN, Chatzigianni E, PapanikolaouS, Karatzas G. E-cadherin expression as a differentiation marker in gastric cancer. Hepatogastroenterology 1998; 45:2437-2442.
  • 3Zheng ZH, Sun XJ, Ma MC, Hao DM, Liu YH, Sun KL. Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer. Yichuan Xuebao 2003; 30:103-108.
  • 4Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004; 1014:155-163.
  • 5Mareel MM, Behrens J, Birchmeier W, De Bruyne GK,Vleminckx K, Hoogewijs A, Fiefs WC, Van Roy FM. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 1991; 47:922-928.
  • 6Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993; 5:806-811.
  • 7Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002; 84:255-268.
  • 8Gooding JM, Yap KL, Ikura M. The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays 2004; 26:497-511.
  • 9Gottardi CJ, Gumbiner BM. Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol 2001; 11:792-794.
  • 10Wong AS, Gumbiner BM. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 2003; 161:1191-1203.

共引文献40

同被引文献15

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部